These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Sørensen PS; Jensen PE; Haghikia A; Lundkvist M; Vedeler C; Sellebjerg F; Koch-Henriksen N; Fogdell-Hahn A; Myhr KM; Hillert J; Gold R Mult Scler; 2011 Sep; 17(9):1074-8. PubMed ID: 21511692 [TBL] [Abstract][Full Text] [Related]
10. Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease. Ko HH; Bressler B Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):29-39. PubMed ID: 19072431 [TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Yeung J; Cauquil C; Saliou G; Nasser G; Rostomashvili S; Adams D; Théaudin M Neurology; 2013 May; 80(19):1812-3. PubMed ID: 23616161 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic value of alpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab. Ghosh S Expert Opin Biol Ther; 2003 Sep; 3(6):995-1000. PubMed ID: 12943458 [TBL] [Abstract][Full Text] [Related]
13. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755 [TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab. Langer-Gould A; Steinman L Curr Neurol Neurosci Rep; 2006 May; 6(3):253-8. PubMed ID: 16635435 [TBL] [Abstract][Full Text] [Related]
15. Asymptomatic reactivation of JC virus in patients treated with natalizumab. Chen Y; Bord E; Tompkins T; Miller J; Tan CS; Kinkel RP; Stein MC; Viscidi RP; Ngo LH; Koralnik IJ N Engl J Med; 2009 Sep; 361(11):1067-74. PubMed ID: 19741227 [TBL] [Abstract][Full Text] [Related]
16. Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis. Nakamura M; Itani K; Miyake K; Kunieda T; Kaneko S; Kusaka H Intern Med; 2017; 56(2):211-214. PubMed ID: 28090055 [TBL] [Abstract][Full Text] [Related]